DIFFERENTIAL-EFFECTS OF GLUTATHIONE DEPLETION ON T-CELL SUBSETS

被引:67
作者
GMUNDER, H
DROGE, W
机构
[1] Division of Immunochemistry, Institute of Immunology and Genetics, German Cancer Research Center, D-6900 Heidelberg
关键词
D O I
10.1016/0008-8749(91)90147-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glutathione (GSH) is known to play an important role in various lymphocyte functions. We now report that different T cell subsets express different requirements for intracellular GSH. Depletion of intracellular GSH by buthionine sulfoximine (BSO), a specific inhibitor of GSH biosynthesis, decreases the proportion of CD8+ cells (i.e., increases the CD4+ CD8+ ratio), and inhibits particularly the generation of large blast-like CD8+ cells and cytotoxic T lymphocyte (CTL) activity. CTL activity is restored by administration of exogenous GSH. Differential effects of GSH depletion were also seen at the level of individual T cell clones. The CD4+ helper T cell clone D10.G4.1.HD was found to express a high rate of interleukin 2 (IL-2) dependent DNA synthesis even after severe depletion of intracellular GSH, whereas other T cell clones including the clone 29 were severely inhibited by BSO. The results of these studies suggest that the decreased intracellular GSH levels of HIV-1 seropositive persons are probably not (directly) responsible for the selective depletion of the CD4+ T cell subset but may be responsible for a cellular dysfunction of the CD8+ subset and for the ultimate failure of the CTL to control the viral infection in these patients. © 1991.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 36 条
[1]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[2]  
BEVAN MJ, 1975, J IMMUNOL, V114, P559
[3]   PERIPHERAL-BLOOD MONONUCLEAR CELL ABNORMALITIES AND THEIR RELATIONSHIP TO CLINICAL COURSE IN HOMOSEXUAL MEN WITH HIV INFECTION [J].
DEMARTINI, RM ;
TURNER, RR ;
FORMENTI, SC ;
BOONE, DC ;
BISHOP, PC ;
LEVINE, AM ;
PARKER, JW .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (02) :258-271
[4]  
DEPAOLI P, 1988, CLIN EXP IMMUNOL, V74, P317
[5]  
DROGE W, 1984, J IMMUNOL, V132, P2749
[6]   LOW CONCENTRATIONS OF ACID-SOLUBLE THIOL (CYSTEINE) IN THE BLOOD-PLASMA OF HIV-1-INFECTED PATIENTS [J].
ECK, HP ;
GMUNDER, H ;
HARTMANN, M ;
PETZOLDT, D ;
DANIEL, V ;
DROGE, W .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1989, 370 (02) :101-108
[7]   QUANTITATIVE CHANGES IN T-HELPER OR T-SUPPRESSOR CYTO-TOXIC LYMPHOCYTE SUBSETS THAT DISTINGUISH ACQUIRED IMMUNE-DEFICIENCY SYNDROME FROM OTHER IMMUNE SUBSET DISORDERS [J].
FAHEY, JL ;
PRINCE, H ;
WEAVER, M ;
GROOPMAN, J ;
VISSCHER, B ;
SCHWARTZ, K ;
DETELS, R .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :95-100
[8]  
FALK W, 1983, J IMMUNOL, V130, P2214
[9]  
FANGER MW, 1970, J IMMUNOL, V105, P1043
[10]   ENHANCEMENT OF INTRACELLULAR GLUTATHIONE PROMOTES LYMPHOCYTE-ACTIVATION BY MITOGEN [J].
FIDELUS, RK ;
TSAN, MF .
CELLULAR IMMUNOLOGY, 1986, 97 (01) :155-163